Trials / Sponsors / InnoCare Pharma Inc.
InnoCare Pharma Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase I Study of ICP-332 in Healthy Subjects Healthy Subjects | Phase 1 | 2024-07-23 |
| Recruiting | A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL Mantle Cell Lymphoma | Phase 3 | 2024-05-29 |
| Recruiting | Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Mature B-cell Malignancies | Phase 1 | 2024-04-23 |
| Unknown | Evaluating Different Doses of Orelabrutinib in MCL Mantle Cell Lymphoma | Phase 2 | 2023-08-18 |
| Unknown | Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2021-07-30 |